Sort by

Send to

Choose Destination

Links from PubMed

Items: 6


SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.

Hussenet T, Dali S, Exinger J, Monga B, Jost B, Dembelé D, Martinet N, Thibault C, Huelsken J, Brambilla E, du Manoir S.

PLoS One. 2010 Jan 29;5(1):e8960. doi: 10.1371/journal.pone.0008960.


Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?

Bastide K, Ugolin N, Levalois C, Bernaudin JF, Chevillard S.

Lung Cancer. 2010 Apr;68(1):1-9. doi: 10.1016/j.lungcan.2009.11.001. Review.


Role of oncogenes and tumour suppressor genes in human lung carcinogenesis.

Harris CC, Reddel R, Pfeifer A, Iman D, McMenamin M, Trump BF, Weston A.

IARC Sci Publ. 1991;(105):294-304. Review.


The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung.

Karachaliou N, Rosell R, Viteri S.

Transl Lung Cancer Res. 2013 Jun;2(3):172-9. doi: 10.3978/j.issn.2218-6751.2013.01.01. Review.


[Advances on driver oncogenes of squamous cell lung cancer].

Hong W, Zhang Y.

Zhongguo Fei Ai Za Zhi. 2014 May;17(5):433-6. doi: 10.3779/j.issn.1009-3419.2014.05.13. Review. Chinese.


Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis.

Shahryari A, Jazi MS, Samaei NM, Mowla SJ.

Front Genet. 2015 Jun 17;6:196. doi: 10.3389/fgene.2015.00196. Review.

Items per page

Supplemental Content

Support Center